Compounds > troglitazone
Page last updated: 2024-11-05

troglitazone and Edema, Pulmonary

troglitazone has been researched along with Edema, Pulmonary in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K1
Sano, H1
Thomas, ML1
Lloyd, SJ1

Other Studies

2 other studies available for troglitazone and Edema, Pulmonary

ArticleYear
Troglitazone-induced pulmonary edema.
    Archives of internal medicine, 2000, Mar-27, Volume: 160, Issue:6

    Topics: Antioxidants; Chromans; Humans; Hypoglycemic Agents; Pulmonary Edema; Thiazoles; Thiazolidinediones;

2000
Pulmonary edema associated with rosiglitazone and troglitazone.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:1

    Topics: Aged; Chromans; Diabetes Mellitus, Type 2; Humans; Male; Pulmonary Edema; Rosiglitazone; Thiazoles;

2001